Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial. [PDF]
Hsu PI +19 more
europepmc +1 more source
Phenotypic and Genotypic Characterization of Antimicrobial Resistance in <i>Helicobacter pylori</i>: Association of <i>23S rRNA</i>, <i>gyrA</i>, and <i>rdxA</i> Gene Mutations With Resistance Patterns. [PDF]
Makled AF +5 more
europepmc +1 more source
Mechanism-matched <i>Helicobacter pylori</i> treatment in the potassium-competitive acid blocker era. [PDF]
Alnounou A, Sieloff EM.
europepmc +1 more source
Efficacy of drug regimens containing omadacycline in a murine model of <i>Mycobacterium avium</i> chronic lung infection. [PDF]
Lanoix JP +10 more
europepmc +1 more source
<i>Helicobacter pylori</i> eradication: a narrative review. [PDF]
Fadelelmoula T +4 more
europepmc +1 more source
Association of Resistance-Associated <i>23S rRNA</i> and <i>gyrA</i> Mutations with Antimicrobial Resistance and Eradication Outcomes in <i>Helicobacter pylori</i>. [PDF]
Matei SD +8 more
europepmc +1 more source
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care. [PDF]
Alispahic IA +8 more
europepmc +1 more source
Sequence of Antibiotic Administration for the Treatment of <i>Mycobacterium avium</i> subsp. <i>hominissuis</i> Infection Might Influence the Response Outcome. [PDF]
Leestemaker-Palmer A +2 more
europepmc +1 more source
<i>Helicobacter pylori</i> Eradication in the Era of Antibiotic Resistance: From Universal Regimens to Precision-Guided Management. [PDF]
Elbehiry A, Marzouk E.
europepmc +1 more source

